InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-10 · accession 0001127602-22-017336 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-06-13 2022-06-10 GILD Dickinson Andrew D CFO M - OptEx — +4,672 69.0K +7% —
D 2022-06-13 2022-06-10 GILD Dickinson Andrew D CFO F - Tax $60.74 -1,969 67.1K -3% -$119.6K
DM 2022-06-13 2022-06-10 GILD Dickinson Andrew D CFO M - OptEx — -4,672 48.5K -9% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-10 M A 3,646 — 67,999 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2 Common Common Stock 2022-06-10 M A 1,026 — 69,025 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Common Common Stock 2022-06-10 F D 1,969 $60.74 67,056 D — —
4 Derivative Restricted Stock Unit 2022-06-10 M D 3,646 — 49,478 D — · — to — 3,646 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
5 Derivative Restricted Stock Unit 2022-06-10 M D 1,026 — 48,452 D — · — to — 1,026 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.